Sue is a senior editor based in Washington, DC, and primarily covers US drug, biologic and biosimilar regulation and policy across therapeutic areas, with an emphasis on advisory committee reviews and FDA approvals. She also covers generic drug and biosimilar patent litigation and other legal issues.
Sue has reported on the prescription and over-the-counter drug industries since 1999 for various publications now under the umbrella of Informa Business Intelligence, including Pink Sheet, "The Pink Sheet" DAILY, "The Tan Sheet" and Scrip. Previously she worked as an editor for Mealey's Litigation Reports (now part of Lexis-Nexis), writing about asbestos, toxic tort and fen-phen litigation. She grew up in South Jersey, where her love for the Philadelphia Phillies and Eagles and home-grown tomatoes was deeply engrained.